Meridian Bioscience (VIVO) Posts Q4 adj.-EPS of $0.15, Shy of Views; Declares $0.19 Quarterly Dividend; 3.2% Yield; Reaffirms FY11 Outlook
Tweet Send to a Friend
Meridian Bioscience (Nasdaq: VIVO) reports Q4 non-GAAP EPS of $0.15, versus the consensus of $0.18. Revenue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
